Morus alba L. for Blood Sugar Management: A Systematic Review and Meta-Analysis

Hye In Jeong; Soobin Jang; Kyeong Han Kim

doi:10.1155/2022/9282154

Morus alba L. for Blood Sugar Management: A Systematic Review and Meta-Analysis

Evid Based Complement Alternat Med. 2022 May 23:2022:9282154. doi: 10.1155/2022/9282154. eCollection 2022.

Authors

Hye In Jeong¹, Soobin Jang², Kyeong Han Kim³

Affiliations

¹ Department of Preventive Medicine, College of Korean Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.
² Department of Preventive Medicine, College of Korean Medicine, Daegu Haany University, Gyeongsan 38610, Republic of Korea.
³ Department of Preventive Medicine, College of Korean Medicine, Woosuk University, Wanju 55338, Republic of Korea.

Abstract

Introduction: Morus alba L. is used for blood sugar management in patients with diabetes mellitus. This review aimed to evaluate the effect of Morus alba on blood sugar management.

Methods: This review was conducted in accordance with the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P). We searched PubMed, EMBASE, and four Korean medical databases (RISS, OASIS, NDSL, and KISS) using relevant keywords. Randomized controlled trials with any type of control intervention were included. The selection of studies, data extraction, and quality assessment were performed independently by two researchers.

Results: Our results showed that Morus alba can reduce postprandial glucose and insulin levels. However, it is insufficient to conclude that Morus alba is an effective intervention for lowering blood glucose levels. Therefore, more rigorous studies are needed to reveal the effect of MA on blood glucose levels.

Conclusion: The conclusion of this review provides evidence that Morus alba can control blood sugar level. This systematic review was registered with the International Prospective Register of Systematic Reviews (PROSPERO) (CRD42021255940).

Publication types

Review